Table 2.
Comparison of patients’ intraoperative and postoperative conditions treated by the three different strategies (n = 51)
| items | mifepristone + misoprostol | mifepristone + Rivanol | hysterotomy | p |
|---|---|---|---|---|
| (n = 16) | (n = 14) | (n = 21) | ||
| Bleeding volume in 24 h of surgery(mL) | 672.50 ± 673.42 | 528.57 ± 610.08 | 752.38 ± 1310.58 | 0.626b |
| Rescue rate (n,%) | 11(68.8) | 8(57.1) | 8(38.1) | 0.168c |
| Blood transfusion rate (n,%) | 6(37.5) | 2(14.3) | 4(19.0) | 0.268c |
| Hysterectomy rate (n, %) | 0(0) | 1(7.1) | 3(14.3) | 0.286c |
| Main operative success rate (n,%) | 5(31.3) | 5(35.7) | 18(85.7) | 0.001c |
| Hospital stay(d) | 10.69 ± 4.38 | 12.79 ± 8.40 | 11.57 ± 3.11 | 0.795b |
| Blood β-hCG decline of 3rd days after treatment (%) | 92.79 ± 8.81 | 91.96 ± 8.33 | 91.85 ± 6.55 | 0.354b |
| Time of β-hCG recovery (d) | 40.06 ± 1.56* | 37.21 ± 2.39 | 32.95 ± 1.79* | 0.028a |
| Time of menstrual recovery (d) | 54.13 ± 2.67 | 55.50 ± 5.05 | 48.24 ± 4.03 | 0.195b |
| Residual placenta | 0.739c | |||
| Expecting treatment | 3(18.8) | 4(28.6) | 3(15.0) | |
| Medical treatment | 10(62.5) | 6(42.9) | 10(50.0) | |
| Surgical treatment | 3(18.8) | 4(28.6) | 7(35.0) |
Data are presented as mean ± SD and count (%)
aOne-way analysis of variance, brank sum test of multiple independent samples, c χ2 test. *Bonferroni adjustment p < 0.017